Feb 16, 2021 | Webinar

What is the place of urinary markers in NMIBC follow-up?

Watch the webinar by Prof. Fred Witjes

On Thursday 21 January 2021, MML-Medical, partner of Nucleix in the Netherlands, organised the webinar “Follow-up of NMIBC, including the place of urinary markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred Witjes, Professor of oncological urology, and 15 minutes Q&A, chaired by Dr. Toine van der Heijden, oncological urologist, both from the Radboud UMC Nijmegen, the Netherlands.

Watch this webinar to learn more about:

The current guidelines on treatment and follow-up of Non Muscle-Invasive Bladder Cancer (NMIBC)
The pitfalls of the current follow-up procedures
Urinary markers in follow-up of NMIBC and promising results from clinical studies
Practical considerations about using biomarker tests in clinical practice

Download the free slide resource and brochure

Share this on your favourite network:

All updates

Other updates

Exploring the benefits of urinary biomarkers in NMIBC surveillance

Apr 30, 2024 | Interview

Watch the interviews with expert urologists Dr. Félix Guerrero-Ramos and Prof. Dr. Fred Witjes sharing their clinical experiences about alternating cystoscopies with urinary biomarkers in the follow-up schedule of patients with non-muscle-invasive bladder cancer...

The diagnostic value of urinary biomarkers in UTUC

Feb 2, 2024 | Publication

Reviewed by Mr. Hugh Mostafid (Royal Surrey County Hospital, Guildford, UK) UTUC: similarities and differences compared to bladder cancer While bladder tumours account for 90-95% of all urothelial carcinomas (UCa), only 5-10% of UCa cases involve the upper urinary...

Including Bladder EpiCheck® in NMIBC surveillance leads to a major reduction in healthcare costs

Jan 19, 2024 | Publication

Urinary biomarker tests, including Bladder EpiCheck®, are reimbursed from January 2024 in the Netherlands Reviewed by Prof. Joost Boormans (Erasmus MC Cancer Institute, Rotterdam, The Netherlands) Pitfalls of the current standard for NMIBC follow-up Due to the high...

Privacy policy

Disclaimers

✉ info@bcamonitor.org